Alerts for Daptomycin

Title	Date Published	Source
L’AFFSAPS alerte les professionnels de santé sur le risque de survenue d’un type rare de pneumonie sous traitement par CUBICIN (daptomycine)	2011-03-10
Novartis Alerts Healthcare Professionals to The Association Of Eosinophilic Pneumonia With Daptomycin Use	2011-03-08
Novartis warnt Aerzte vor einer schwerwiegenden Nebenwirkung des Antibiotikums Cubicin (Daptomycin)	2011-02-02
FDA Warns about Risk of Developing Rare Type of Pneumonia During Treatment With Cubicin	2010-07-29

See alerts for all drugs

DISCLAIMER: MediGuard is not intended to be a substitute for professional medical advice. MediGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the MediGuard site and its content is at your own risk. The MediGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

HACKER SAFE certified sites prevent over 99.9% of hacker crime.